rTMS ameliorates depressive‐like behaviors and regulates the gut microbiome and medium‐ and long‐chain fatty acids in mice exposed to chronic unpredictable mild stress

Cui‐Hong Zhou,Yi‐Huan Chen,Shan‐Shan Xue,Qing‐Qing Shi,Lin Guo,Huan Yu,Fen Xue,Min Cai,Hua‐Ning Wang,Zheng‐Wu Peng

DOI: https://doi.org/10.1111/cns.14287

2023-06-03

Abstract:rTMS (15 Hz, 1.26 T) alleviates depressive‐like behavior of CUMS‐treated mice and regulates the flora represented by Cyanobacterium and Actinobaciota. Meanwhile, it improves polyunsaturated fatty acids (PUFAs) in hippocampus and PFC, and also upregulates C20:4N6, C20:5N3 and C20:3N3 PUFAs in the plasma. Introduction Repetitive transcranial magnetic stimulation (rTMS) is a clinically useful therapy for depression. However, the effects of rTMS on the metabolism of fatty acids (FAs) and the composition of gut microbiota in depression are not well established. Methods Mice received rTMS (15 Hz, 1.26 T) for seven consecutive days after exposure to chronic unpredictable mild stress (CUMS). The subsequent depressive‐like behaviors, the composition of gut microbiota of stool samples, as well as medium‐ and long‐chain fatty acids (MLCFAs) in the plasma, prefrontal cortex (PFC), and hippocampus (HPC) were evaluated. Results CUMS induced remarkable changes in gut microbiotas and fatty acids, specifically in community diversity of gut microbiotas and PUFAs in the brain. 15 Hz rTMS treatment alleviates depressive‐like behaviors and partially normalized CUMS induced alterations of microbiotas and MLCFAs, especially the abundance of Cyanobacteria, Actinobacteriota, and levels of polyunsaturated fatty acids (PUFAs) in the hippocampus and PFC. Conclusion These findings revealed that the modulation of gut microbiotas and PUFAs metabolism might partly contribute to the antidepressant effect of rTMS.

pharmacology & pharmacy,neurosciences